Literature DB >> 6707943

Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.

S Nattel, F D Zeng.   

Abstract

Antiarrhythmic drugs are known to have frequency dependent effects on Vmax and conduction. The purpose of this study was to determine whether the effects of antiarrhythmic drugs on action potential duration (APD) and refractory period depend on frequency. Standard microelectrode techniques were used to measure APD and refractory period after abrupt or sustained alterations in stimulation frequency. Increases in APD95 resulting from bretylium and quinidine and decreases resulting from lidocaine were 50 to 60% attenuated (P less than .01 for each) by sustained increases in activation rate. Unlike sustained rate increases, abrupt increases in rate enhanced quinidine-induced APD prolongation (P less than .01). Quinidine increased the time constant (222 +/- 6 to 346 +/- 36 msec, P less than .01) and decreased the magnitude of the rapid phase of APD abbreviation upon premature stimulation. In contrast, bretylium increased the magnitude of APD abbreviation upon premature stimulation, reducing the tendency of bretylium to prolong premature APD compared to basic APD. Changes in refractory period parallelled changes in APD95 with the exception of the effect of quinidine after sustained rate change. Despite attenuation of its effects oN APD95, quinidine prolonged refractory period more after sustained rate increases (P less than .01), apparently because of greater depression of maximum sodium conductance. These experiments show that the effects of antiarrhythmic drugs on APD and refractoriness depend on activation frequency and that abrupt changes in rate may alter drug effects differently from sustained rate changes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707943

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Role of slow delayed rectifying potassium current in dynamics of repolarization and electrical memory in swine ventricles.

Authors:  Linyuan Jing; Kathleen Brownson; Abhijit Patwardhan
Journal:  J Physiol Sci       Date:  2014-03-30       Impact factor: 2.781

2.  Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization.

Authors:  L Yue; J Feng; G R Li; S Nattel
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

Review 3.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

4.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

5.  Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine Purkinje fibres.

Authors:  A Varrò; T K Knilans; P P Nànàsi; G Rabloczky; D A Lathrop
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

6.  Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax.

Authors:  T K Knilans; D A Lathrop; P P Nánási; A Schwartz; A Varró
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent.

Authors:  D A Lathrop; A Varró
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

8.  Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.

Authors:  Y Nakaya; V Elharrar; B Surawicz
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

9.  A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.

Authors:  B J Northover
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

10.  Differential effects of quinidine and flecainide on plateau duration of human atrial action potential.

Authors:  S Hatem; B Le Grand; J Y Le Heuzey; J P Couétil; E Deroubaix
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.